Citigroup
WHWK

Citigroup’s Whitehawk Therapeutics WHWK Stock Holding History

Citigroup’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.2K Buy
+6,159
New +$19.3K ﹤0.01% 4805
2025
Q2 		– Sell
-75
Closed -$134 – 5965
2025
Q1 		$134 Hold
75
– – ﹤0.01% 5429
2024
Q4 		$237 Sell
75
-6
-7% -$14 ﹤0.01% 5656
2024
Q3 		$167 Sell
81
-2,676
-97% -$4.33K ﹤0.01% 5520
2024
Q2 		$4.03K Sell
2,757
-840
-23% -$1.56K ﹤0.01% 5277
2024
Q1 		$8.42K Buy
3,597
+1,275
+55% +$2.46K ﹤0.01% 5240
2023
Q4 		$4.69K Buy
2,322
+1,904
+456% +$7.99K ﹤0.01% 5342
2023
Q3 		$2.02K Sell
418
-4,419
-91% -$25.7K ﹤0.01% 4952
2023
Q2 		$33.1K Buy
4,837
+4,836
+483,600% +$37.6K ﹤0.01% 4823
2023
Q1 		$7 Sell
1
-98
-99% -$1.05K ﹤0.01% 5417
2022
Q4 		$1.27K Sell
99
-121
-55% -$1.58K ﹤0.01% 5358
2022
Q3 		$3K Sell
220
-17,469
-99% -$230K ﹤0.01% 5431
2022
Q2 		$218K Sell
17,689
-8,300
-32% -$123K ﹤0.01% 3805
2022
Q1 		$441K Sell
25,989
-10,177
-28% -$195K ﹤0.01% 3601
2021
Q4 		$873K Buy
36,166
+35,518
+5,481% +$892K ﹤0.01% 3386
2021
Q3 		$19K Buy
+648
New +$19.8K ﹤0.01% 5260
2019
Q1 		– Sell
-16,131
Closed -$411K – 7846
2018
Q4 		$411K Buy
+16,131
New +$514K ﹤0.01% 4341

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Citigroup's WHWK Position: Q1 2026 in Review

Citigroup opened a new position in Whitehawk Therapeutics (WHWK) in Q1 2026: 6,159 shares worth $21.2K. The stake represents ﹤0.01% of the portfolio and ranks #4805 among its holdings. This is a return to the name: Citigroup previously reported a position in WHWK as recently as Q1 2025.

Citigroup first reported a position in WHWK in Q4 2018 and has held it in 17 quarters since. The position peaked at $873K in Q4 2021. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Citigroup held 6,159 shares of Whitehawk Therapeutics worth $21.2K as of Q1 2026.
  • Whitehawk Therapeutics was a new Citigroup position in Q1 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4805 holding.
  • Citigroup first reported a position in Whitehawk Therapeutics in Q4 2018 and has held it in 17 quarters since.
  • Citigroup's Whitehawk Therapeutics position peaked at $873K in Q4 2021.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.